The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Published Online:https://doi.org/10.1176/ajp.128.2.174

A group of 46 children in kindergarten through fourth grade whom their teachers considered to have severe behavior and/or learning disorders were randomly assigned to receive dextroamphetamine or placebo in a double-blind crossover design. D-amphetamine produced behavioral improvement that was clearly distinguishable from placebo effects in 25 children (54 percent of the study population). This represents seven percent of the total school population. The greatest improvement was seen in children with at least one hard neurological sign or two or more soft signs and a high hyperkinetic syndrome score. However, until a method of picking children with a bad prognosis is known, large-scale case finding in the schools with recommendation for long-term d-amphetamine treatment is not advised.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.